Study of Dexycu in Treating Intraocular Inflammation

Summary

This is a phase III, prospective, randomised, double-masked, placebo-controlled, parallel-design, multicenter study of the efficacy, safety and pharmacokinetics of 9% dexamethasone intraocular injection for the treatment of inflammation associated with cataract surgery.

Timeline

Start

2022-08-22

Primary completion

2023-11-24

Completion

2024-04-09

Drugs

Indications